Oxford tests Dual-Action malaria shot in babies
NCT ID NCT05357560
Summary
This early-stage study is testing the safety and immune response of two new malaria vaccine candidates. One vaccine targets the malaria parasite in the liver, while the other targets it in the blood. Researchers are giving the vaccines separately and together to 107 healthy adults and infants in The Gambia to see how well they are tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA (PLASMODIUM FALCIPARUM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical Research Council Unit, Fajara
Banjul, PO Box 273, The Gambia
Conditions
Explore the condition pages connected to this study.